AKT1 and hyperuricemia: Our results showed that the activation of the PI3K/AKT/NF-κB pathway in hyperuricemia-induced renal injury was blocked by AZ3451 treatment, indicating that this pathway is involved in the protective effects of AZ3451 in hyperuricemia-induced renal injury.